Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Endocrinology

• Publication date

  2002-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/EN.2002-220120PMID 12446610
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aldosterone induces a vascular inflammatory phenotype in the rat heart.

  2002cited by this paper
• Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-&kgr;B Activation in Angiotensin II–Induced Cardiac Injury

  2001influential reference
• Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration.

  2001cited by this paper
• Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

  2001cited by this paper
• Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.

  2000cited by this paper
• Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.

  2000cited by this paper
• Cyclooxygenase-2 is required for tumor necrosis factor-alpha- and angiotensin II-mediated proliferation of vascular smooth muscle cells.

  2000cited by this paper
• Osteopontin augments CD3‐mediated interferon‐γ and CD40 ligand expression by T cells, which results in IL‐12 production from peripheral blood mononuclear cells

  2000cited by this paper
• Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues.

  2000cited by this paper
• Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease.

  2000cited by this paper
• Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

  2000cited by this paper
• Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart.

  2000influential reference
• Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension.

  1999cited by this paper
• Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

  1998cited by this paper
• Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats.

  1998cited by this paper
• Mineralocorticoids, salt, hypertension: effects on the heart.

  1996cited by this paper
• Angiotensin II induction of osteopontin expression and DNA replication in rat arteries.

  1996cited by this paper
• Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.

  1996cited by this paper
• Biological determinants of aldosterone-induced cardiac fibrosis in rats.

  1995cited by this paper
• Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.

  1993cited by this paper
• Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro.

  1993cited by this paper
• Enalapril Prevents Stroke and Kidney Dysfunction in Salt‐Loaded Stroke‐Prone Spontaneously Hypertensive Rats

  1989cited by this paper
• Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium.

  1976cited by this paper
• Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II.

  1971cited by this paper

• The Role of Aldosterone in Vascular Permeability in Diabetes

  2026cites this paper
• Finerenone in Atrial Fibrillation: Molecular Mechanisms and Emerging Clinical Evidence

  2026cites this paper
• High salt intake exacerbates aldosterone-related target organ damage in patients with primary aldosteronism

  2025cites this paper
• Primary Aldosteronism and Risk of Cardiovascular Outcomes: Genome‐Wide Association and Mendelian Randomization Study

  2024cites this paper
• Aldosterone Antagonism Is More Effective at Reducing Blood Pressure and Excessive Renal ENaC Activity in AngII-Infused Female Rats Than in Males

  2023cites this paper
• Extra-adrenal aldosterone: a mini review focusing on the physiology and pathophysiology of intrarenal aldosterone

  2023cites this paper
• Salt and Aldosterone – Reciprocal and Combined Effects in Preclinical Models and Humans

  2023cites this paper
• Transcriptional changes during isoproterenol-induced cardiac fibrosis in mice

  2023cites this paper
• Detection and modification of biomarkers of inflammation determining successful rhythm control in patients with atrial fibrillation

  2023cites this paper
• Eplerenone modulates the inflammatory response in monosodium iodoacetate-induced knee osteoarthritis in rats: Involvement of RANKL/OPG axis.

  2023cites this paper
• Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling

  2023cites this paper
• Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review.

  2022cites this paper
• Vascular and hormonal interactions in the adrenal gland

  2022cites this paper
• Clinical Characteristics of Target Organ Damage in Primary Aldosteronism with or without Metabolic Syndrome

  2022cites this paper
• Radiation Induced Lung Injury (RILI) and COVID-19 Pneumonia: Are There Similarities by The Radiation Oncologist’s Point of View?

  2022cites this paper
• Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects

  2022cites this paper
• Aldosterone Increases Vascular Permeability in Rat Skin

  2022cites this paper
• An Overview of the Classical and Tissue-derived Renin-Angiotensin-Aldosterone System and its Genetic Polymorphisms in Essential Hypertension.

  2020cites this paper
• [Single Pill Indapamide and Perindopril Arginine Combination: Optimal Coupling of Vascular Protection and Hemodynamic Risk Factors Reduction in Patients with Essential Arterial Hypertension].

  2019cites this paper
• PKC-delta mediates mineralocorticoid receptor activation by angiotensin II to modulate smooth muscle cell function.

  2019cites this paper
• Nobiletin Prevents Trimethylamine Oxide-Induced Vascular Inflammation via Inhibition of the NF-κB/MAPK Pathways.

  2019cites this paper
• [Mechanisms for the Development of Blood Pressure Variability and the Potential of Antihypertensive Drugs in Their Correction].

  2019cites this paper
• Regulatory T cells protected against abdominal aortic aneurysm by suppression of the COX‐2 expression

  2019cites this paper
• Gene expression and gene associations during the development of heart failure with preserved ejection fraction in the Dahl salt sensitive model of hypertension

  2018cites this paper
• Primary Aldosteronism and Cerebrovascular Diseases

  2018cites this paper
• Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II

  2018cites this paper
• Evaluation of the inhibitory effects of telmisartan on drug-induced renin-angiotensin-aldosterone system activation in normal dogs.

  2018cites this paper
• Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.

  2018cites this paper
• Smooth Muscle Cell–Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging

  2018cites this paper
• Urotensin II promotes aldosterone expression in rat aortic adventitial fibroblasts

  2017cites this paper
• Novel Pathophysiological Mechanisms in Hypertension.

  2017cites this paper
• Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association.

  2017cites this paper
• Mineralocorticoid regulation of cell function: the role of rapid signalling and gene transcription pathways.

  2017cites this paper
• Characterization and Functional Beverage Development using Coenzyme Q10-Impregnated Beta-glucan

  2017cites this paper
• The role of spironolactone on myocardial oxidative stress in rat model of streptozotocin‐induced diabetes

  2017cites this paper
• Mineralocorticoid receptor antagonists in dialysis patients

  2016cites this paper
• Pathophysiological role of osteopontin and angiotensin II in atherosclerosis.

  2016cites this paper
• Activated mineralocorticoid receptor regulates micro‐RNA‐29b in vascular smooth muscle cells

  2016cites this paper
• Aldosterone in vascular and metabolic dysfunction

  2016cites this paper
• Mineralocorticoid Receptor Blockade Lowers Blood Pressure and Improves Endothelial Function in Obese Patients with Metabolic Syndrome

  2016cites this paper
• Does Aldosterone Play a Significant Role for Regulation of Vascular Tone?

  2016cites this paper
• Evaluation of the effect of an angiotensin-converting enzyme inhibitor, alacepril, on drug-induced renin-angiotensin-aldosterone system activation in normal dogs.

  2016cites this paper
• Endocrine Hypertension and Chronic Kidney Disease

  2015cites this paper
• Targeting Tissue-Specific Enzymatic Cascades of Local Angiotensin System in Human Atheroma

  2015cites this paper
• Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II‐infused rats

  2015cites this paper
• Chronic kidney disease and hypertension

  2015cites this paper
• Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.

  2015cites this paper
• Role of mineralocorticoid receptor antagonists in cardiovascular disease.

  2015cites this paper
• Plasma Aldosterone Concentration Is Positively Associated With Pulse Pressure in Patients With Primary Hypertension

  2015cites this paper
• Effects of Add-on Therapy Consisting of a Selective Mineralocorticoid Receptor Blocker on Arterial Stiffness in Patients with Uncontrolled Hypertension.

  2015cites this paper
• Coenzyme Q10 treatment of cardiovascular disorders of ageing including heart failure, hypertension and endothelial dysfunction.

  2015cites this paper
• Inflammation and Arterial Hypertension: From Pathophysiological Links to Risk Prediction.

  2015cites this paper
• Aldosterone Promotes Vascular Remodeling by Direct Effects on Smooth Muscle Cell Mineralocorticoid Receptors

  2014cites this paper
• Mineralocorticoid receptor blockade inhibits accelerated atherosclerosis induced by a low sodium diet in apolipoprotein E-deficient mice

  2014cites this paper
• Effects of aldosterone on insulin sensitivity and secretion.

  2014cites this paper
• Inflammation markers in essential hypertension.

  2014cites this paper
• Beneficial Effects of Proanthocyanidins in the Cardiac Alterations Induced by Aldosterone in Rat Heart through Mineralocorticoid Receptor Blockade

  2014cites this paper
• Relevance of SGK1 in structural, functional and molecular alterations produced by aldosterone in heart

  2014cites this paper
• Ferrario and Schiffrin Aldosterone Antagonism in Cardiovascular Disease 207

  2014cites this paper
• Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes

  2014cites this paper
• Lack of RAAS inhibition by high-salt intake is associated with arterial stiffness in hypertensive patients

  2014cites this paper
• Oxidative DNA Damage in Kidneys and Heart of Hypertensive Mice Is Prevented by Blocking Angiotensin II and Aldosterone Receptors

  2014cites this paper
• Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients.

  2014cites this paper
• Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function.

  2014cites this paper
• Mecanismos moleculares implicados en el daño miocárdico inducido por diabetes: efectos del bloqueo de los receptores de aldosterona

  2013cites this paper
• Adrenalectomy amplifies aldosterone induced injury in cardiovascular tissue: an effect attenuated by adrenally derived steroids.

  2013cites this paper
• Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats.

  2013cites this paper
• Vascular mineralocorticoid receptors regulate blood pressure effects on myogenic tone and role in aging.

  2013cites this paper
• Organ failure as an expression of organ remodeling. Involvement of oxidative stress

  2013cites this paper
• Aldosterone Mediates Cardiac Fibrosis in the Setting of Hypertension

  2013cites this paper
• Mineralocorticoid receptors and the heart, multiple cell types and multiple mechanisms: a focus on the cardiomyocyte.

  2013cites this paper
• Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma

  2013cites this paper
• Eplerenone: A Review of Its Use in Patients with Chronic Systolic Heart Failure and Mild Symptoms

  2013cites this paper
• The Renin-Angiotensin System, Capri 2005

  2013cites this paper
• Pathophysiology of Heart Failure

  2013cites this paper
• Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.

  2013cites this paper
• Targeting the mineralocorticoid receptor in cardiovascular disease

  2013cites this paper
• Renin inhibition and AT(1)R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling.

  2013cites this paper
• Pro-nociceptive role of the activation of mineralocorticoid receptor in the pathogenesis of painful diabetic neuropathy.

  2013cites this paper
• [Dissociation of antihypertensive and metabolic response to losartan and spironolactone in experimental rats with metabolic sindrome].

  2012cites this paper
• Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis.

  2012cites this paper
• The mineralocorticoid receptor-p38MAPK-NFκB or ERK-Sp1 signal pathways mediate aldosterone-stimulated inflammatory and profibrotic responses in rat vascular smooth muscle cells

  2012cites this paper
• Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats

  2012cites this paper
• Eplerenone

  2012cites this paper
• Expression of Angiotensin II and Aldosterone in Radiation-induced Lung Injury

  2012cites this paper
• The role of mineralocorticoid receptor antagonists in patients with American College of Cardiology/American Heart Association stage B heart failure.

  2012cites this paper
• Papel de la quinasa regulada por suero y glucocorticoides 1 en las alteraciones cardiacas producidas por la aldosterona en ratas

  2012cites this paper
• Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury

  2012cites this paper
• T Regulatory Lymphocytes Prevent Aldosterone-Induced Vascular Injury

  2012cites this paper
• arterial hypertension chronic inflammatory disease ?

  2012cites this paper
• Mineralocorticoid receptors in vascular function and disease.

  2012cites this paper
• The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease.

  2012cites this paper
• АЛЬДОСТЕРОН, СЕРДЕЧНО-СОСУДИСТАЯ СИСТЕМА И ПОЧКИ ALDOSTERONE, CARDIOVASCULAR SYSTEM AND KIDNEYS

  2012cites this paper
• Vascular Actions of Aldosterone

  2012cites this paper
• Minelarocorticoid Receptor is Overexpressed in Cardiomyocytes of Patients with Congestive Heart Failure

  2012cites this paper
• Tissue-specific modulation of mineralocorticoid receptor function by 11β-hydroxysteroid dehydrogenases: an overview.

  2012cites this paper
• Extrarenal effects of aldosterone

  2012cites this paper
• Characterization of the Early Cellular Mechanisms Promoting Myocardial Fibrosis

  2012cites this paper
• Non-adrenal synthesis of aldosterone: a reality check.

  2012cites this paper
• Relative kidney hyperfiltration in primary aldosteronism: a meta-analysis

  2011cites this paper